Recent developments in the Global Tumor Ablation Procedure Industry:
# In October 2015, AngioDynamics, Inc. launched its NanoKnife Ablation system in South Korea after receiving regulatory approval by Ministry of Food and Drug Safety (South Korea). This helped AngioDynamics expand its product portfolio for tumor ablation market.
# In July 2016, Boston Scientific Corporation acquired the Cosman Medical Inc. (U.S.) at an undisclosed value. Cosman Medical is a leading manufacturer of radiofrequency ablation devices. This acquisition helped Boston Scientific to strengthen its technological capabilities and to expand its product sales and distribution network in the global tumor ablation market.
# In May 2016, Galil Medical Inc. was acquired by the BTG plc group (a part of BTG International Ltd, U.K.); for a value of USD 110.0 million. BTG International is prominent manufacturer of cryoablation products and possesses strong product distribution network across Europe. The acquisition helped Galil Medical to strengthen its technological capabilities and to expand its distribution network in global tumor ablation market.
# In april 2016, Medtronic plc launched Barrx 360 Express radiofrequency ablation (RFA) balloon catheter; for the treatment of Barrett’s esophagus. It helped the company to provide technologically advanced product to its customers in tumor ablation market.
Major Growth Influencing Factors:
Key factors such growing geriatric population, continuous expansion in population base of cancer patients across the globe, and ongoing technological advancements in the field of tumor ablation product are the major factors driving the growth of the tumor ablation market across the globe.
Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=142550258
Expected Growth Scenario Across Geographies:
North America is expected to account for the largest share of the market during the forecast period
North America is one of the major revenue-generating regions in the global tumor ablation market. The large share of this regional segment can mainly be attributed to early introduction of tumor ablation technologies in the region, continuous technological advancements occurring in the field of tumor ablation catheters, and growing private-public investments to develop innovative tumor ablation technologies (coupled with the growing public awareness related to the benefits of tumor ablation).
Key questions addressed in this Report:
# What are the growth opportunities related to tumor ablation across major regions in the future?
# Emerging countries have immense opportunities for the growth and adoption of tumor ablation products. Will this scenario continue in the next five years?
# Where will all the advancements in products offered by various companies take the industry in the mid- to long-term?
# What are the new trends and advancements in the tumor ablation market?
Applications of the Technology:
On the basis of application, the market is segmented into liver cancer, lung cancer, kidney cancer, bone metastasis, other applications. The liver cancer segment is expected to account for the largest share of the tumor ablation market in 2016.
Factors such as high adoption rate of ablation techniques among healthcare professionals for the treatment of liver carcinoma, significant medical reimbursements available in the US and ~53% reimbursement for liver cancer treatment provided by Medicare, larger proportion of global population exposed to various risk factors for liver cancer as compared to that for other cancer types, and significant life expectancy in patients after liver tumor ablation drive the growth of this segment.
Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=142550258
Global Leaders:
The key players present in the global tumor ablation market focus on various strategies such as product approvals, launches, and enhancements; strategic acquisitions; partnerships, agreements, and collaborations; and geographic expansions in order to increase their shares in the global tumor ablation market.
During 2013-2016, product approvals, launches, and enhancements; and acquisitions were the key strategies adopted by major industry players, including AngioDynamics, Inc. (U.S.), Boston Scientific Corporation (U.S.), Galil Medical (Israel), EDAP TMS S.A. (France), HealthTronics, Inc. (U.S.), Medtronic plc (Ireland), and SonaCare Medical LLC (U.S.).
Other strategies adopted by many prominent players include fund raising from private/government sources to enhance their research & development capabilities; initiatives to increase awareness about tumor ablation; and geographic expansions.
Global Tumor Ablation Research Industry to Undergo Major Transformation in Near Future
UpMarketResearch offers a latest published report on “Global Ablation Catheters Market Industry Analysis and Forecast 2018-2025” delivering key insights and providing a competitive advantage to clients through a detailed report.
It presents a comparative detailed analysis of all the regional and major player segments, offering readers a better knowledge of areas in which they can place their existing resources and gauging the priority of a particular region in order to boost their standing in the global market.
The numerical data is backed up by statistical tools such as SWOT analysis, BCG matrix, SCOT analysis, PESTLE analysis and so on.
The statistics are represented in graphical format for a clear understanding on facts and figures.
The generated report is firmly based on primary research, interviews with top executives, news sources and information insiders.
The major manufacturers covered in this report are:Boston ScientificMedtronicJude MedicalBiosense WebsterVedengMicroPort Scientific CorporationLepu Medical GroupSynaptic MedicalBardCovidien For any queries or more information, visit: https://www.upmarketresearch.com/home/enquiry_before_buying/8417 We can also provide the customized separate regional or country-level reports, for the following regions:North AmericaAsia-PacificEuropeCentral & South AmericaMiddle East & Africa On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into: Multielectrode Ablation CathetersSingle Point Ablation Catheters By Application, the market can be split into:Supraventricular TachycardiaAtrial FibrillationVentricular Tachycardia The Report covers in-depth analysis as follows:Chapter 1 Study CoverageChapter 2 Executive SummaryChapter 3 Breakdown Data by ManufacturersChapter 4 Breakdown Data by ProductChapter 5 Breakdown Data by End UserChapter 6 North AmericaChapter 7 EuropeChapter 8 Asia PacificChapter 9 Central & South AmericaChapter 10 Middle East and AfricaChapter 11 Company ProfilesChapter 12 Future ForecastChapter 13 Market Opportunities, Challenges, Risks and Influences Factors AnalysisChapter 14 Value Chain and Sales Channels AnalysisChapter 15 Research Findings and ConclusionChapter 16 Appendix Buy this report @: https://www.upmarketresearch.com/buy/ablation-catheters-market “Global Ablation Catheters Market Industry Analysis and Forecast 2018-2025” report helps the clients to take business decisions and to understand strategies of major players in the industry.
The global Tumor Ablation market was valued at USD 973.4 million in 2018 and is expected to reach USD 2.30 billion by year 2026, at a CAGR of 11.2 %.
The study covers Tumor Ablation therapy uses some form of energy like radiofrequency, heat, electricity or cold to destroy and remove a tumor.
Tumor ablation has primarily been used for the treatment of esophageal squamous cell dysplasia, gastric antral vascular ectasia, radiation proctopathy, cholangiocarcinoma, and pancreatic neoplasia.
Ablation is preferred over other methods of treatment such as conventional surgery due to multiple advantages like no skin incision minimal risk to patient, little to no pain inflicted and a short duration of hospital stay.
In the year 2016 US the annual cost for cancer was USD 80.2 billion of which 38% cost was estimated due to inpatient hospital stays which can be reduced to quite good extent as the tumor ablation demands short duration of hospital stay.Rising prevalence of target diseases such as lung and liver cancer due to various reasons such as unhealthy living styles and hereditary factor, unmet needs of patients demanding drug developments, increased focus of pharmaceutical companies on development of easier methods of testing and monitoring, entry of various players, private investment and governmental funding, and favorable regulatory scenario, increasing demand for less to no pain treatments are some of the key factors driving the market growth in the industry.
New technological innovation of surgical technology taking place such as development in existing radio frequency ablation system now with multi electrode radio frequency system which produces radiofrequency using multi channels.
Augmented demand for patient-centric models has been shaping the ablation devices market for many years.
Moreover, aggressive shift towards minimal invasion, reduced hospitalization rate, greater clinical efficacy, and lower cost is supporting the market growth.
Therefore, FMI projects the net revenue pool to exceed US$ 8 Bn by 2029 end.“Highly sought-after attributes such as proven procedural efficacy, enhanced safety profiles, and greater awareness are fueling the demand for ablation devices in asymptomatic procedure-related events.
Hence, the global ablation devices market will witness stellar growth at approximately 11% CAGR over the forecast period (2019-2029),” says the FMI analyst.Request report sample with 300 pages to gain in-depth insights https://www.futuremarketinsights.com/reports/sample/rep-gb-11254Key Takeaways of Ablation Devices Market StudyAdvanced ablation catheters will continue to stay atop, accounting for 68% revenue in terms of product type.Radiofrequency technology remains highly preferred by manufacturers across the globe.In terms of function, conventional ablation devices will capture leading value proportion over the forecast period.Clinics and hospitals are prominent end users on account of trained medical staff and greater availability of ablation devices.Europe and North America collectively hold 70% share in the overall market stack.Ablation Devices Market – Key Growth FactorsRising adoption of automated robotic ablation devices is stimulating the market growth.Rapid investments by governments in developed countries towards healthcare infrastructure are complementing the growth of ablation devices market.Advancements in state-of-the-art medical equipment will support the market growth over the projection period.Lesser recovery time and lesser potential risks of radiofrequency technology are boosting its wider adoption.Popularity of cryoablation catheters in treating arrhythmias will support the growth of this segment through 2029.Rising life expectancy combined with growing geriatric population are significant revenue contributors of global ablation devices market.Ablation Devices Market – Key RestraintsPotential damage caused by the use ablation devices at the cellular level is limiting the growth of market.
The medical fraternity is giving preference to treat COVID-19 patients while other elective procedures are being postponed worldwide.
Addressing the economic concerns remains the top priority of niche players in the global ablation devices market.Explore the full ablation devices market report with 238 illustrative figures, 78 data tables and table of contents.
The Tumor Ablation market research report provides the latest industry data, growth, key segments and future trends on the basis of the detailed study.
This market report also allows you to identify the future opportunity and growth rate of the leading segment based on regions and countries.The report also covers detailed competitive landscape including company profiles of key players operating in the global market.
The key players in the tumor ablation market include AngioDynamics, Biotronik, Boston Scientific Corporation, EDAP TMS, ERBE Elektromedizin GmbH, Galil Medical, Inc., HealthTronics, Inc., Medtronic, Mermaid Medical, Misonix Inc., NeuWave Medical, Inc., and SonaCare Medical LLC.
An in-depth view of the competitive outlook includes future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other developments with information in terms of H.Q.Get more information on "Global Tumor Ablation Market Research Report" by requesting FREE Sample Copy at https://www.valuemarketresearch.com/contact/Tumor-Ablation-market/download-sampleMarket DynamicsThe increasing prevalence of cancer coupled with the rising demand for minimally invasive surgeries such as radiofrequency ablation is driving the market growth.
Additionally, rising expenditure in the healthcare industry along with the increasing awareness among people about the tumor ablation technique is further fuelling market growth.
Whereas, ongoing R for tumor ablation techniques and favorable governmental initiatives for cancer treatment are expected to offer an opportunity during the forecast period.This detailed market study is centered on the data obtained from multiple sources and is analyzed using numerous tools including porter’s five forces analysis, market attractiveness analysis, and value chain analysis.
UpMarketResearch offers a latest published report on “Global Ablation Catheters Market Industry Analysis and Forecast 2018-2025” delivering key insights and providing a competitive advantage to clients through a detailed report.
It presents a comparative detailed analysis of all the regional and major player segments, offering readers a better knowledge of areas in which they can place their existing resources and gauging the priority of a particular region in order to boost their standing in the global market.
The numerical data is backed up by statistical tools such as SWOT analysis, BCG matrix, SCOT analysis, PESTLE analysis and so on.
The statistics are represented in graphical format for a clear understanding on facts and figures.
The generated report is firmly based on primary research, interviews with top executives, news sources and information insiders.
The major manufacturers covered in this report are:Boston ScientificMedtronicJude MedicalBiosense WebsterVedengMicroPort Scientific CorporationLepu Medical GroupSynaptic MedicalBardCovidien For any queries or more information, visit: https://www.upmarketresearch.com/home/enquiry_before_buying/8417 We can also provide the customized separate regional or country-level reports, for the following regions:North AmericaAsia-PacificEuropeCentral & South AmericaMiddle East & Africa On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into: Multielectrode Ablation CathetersSingle Point Ablation Catheters By Application, the market can be split into:Supraventricular TachycardiaAtrial FibrillationVentricular Tachycardia The Report covers in-depth analysis as follows:Chapter 1 Study CoverageChapter 2 Executive SummaryChapter 3 Breakdown Data by ManufacturersChapter 4 Breakdown Data by ProductChapter 5 Breakdown Data by End UserChapter 6 North AmericaChapter 7 EuropeChapter 8 Asia PacificChapter 9 Central & South AmericaChapter 10 Middle East and AfricaChapter 11 Company ProfilesChapter 12 Future ForecastChapter 13 Market Opportunities, Challenges, Risks and Influences Factors AnalysisChapter 14 Value Chain and Sales Channels AnalysisChapter 15 Research Findings and ConclusionChapter 16 Appendix Buy this report @: https://www.upmarketresearch.com/buy/ablation-catheters-market “Global Ablation Catheters Market Industry Analysis and Forecast 2018-2025” report helps the clients to take business decisions and to understand strategies of major players in the industry.
The Tumor Ablation market research report provides the latest industry data, growth, key segments and future trends on the basis of the detailed study.
This market report also allows you to identify the future opportunity and growth rate of the leading segment based on regions and countries.The report also covers detailed competitive landscape including company profiles of key players operating in the global market.
The key players in the tumor ablation market include AngioDynamics, Biotronik, Boston Scientific Corporation, EDAP TMS, ERBE Elektromedizin GmbH, Galil Medical, Inc., HealthTronics, Inc., Medtronic, Mermaid Medical, Misonix Inc., NeuWave Medical, Inc., and SonaCare Medical LLC.
An in-depth view of the competitive outlook includes future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other developments with information in terms of H.Q.Get more information on "Global Tumor Ablation Market Research Report" by requesting FREE Sample Copy at https://www.valuemarketresearch.com/contact/Tumor-Ablation-market/download-sampleMarket DynamicsThe increasing prevalence of cancer coupled with the rising demand for minimally invasive surgeries such as radiofrequency ablation is driving the market growth.
Additionally, rising expenditure in the healthcare industry along with the increasing awareness among people about the tumor ablation technique is further fuelling market growth.
Whereas, ongoing R for tumor ablation techniques and favorable governmental initiatives for cancer treatment are expected to offer an opportunity during the forecast period.This detailed market study is centered on the data obtained from multiple sources and is analyzed using numerous tools including porter’s five forces analysis, market attractiveness analysis, and value chain analysis.
The global Tumor Ablation market was valued at USD 973.4 million in 2018 and is expected to reach USD 2.30 billion by year 2026, at a CAGR of 11.2 %.
The study covers Tumor Ablation therapy uses some form of energy like radiofrequency, heat, electricity or cold to destroy and remove a tumor.
Tumor ablation has primarily been used for the treatment of esophageal squamous cell dysplasia, gastric antral vascular ectasia, radiation proctopathy, cholangiocarcinoma, and pancreatic neoplasia.
Ablation is preferred over other methods of treatment such as conventional surgery due to multiple advantages like no skin incision minimal risk to patient, little to no pain inflicted and a short duration of hospital stay.
In the year 2016 US the annual cost for cancer was USD 80.2 billion of which 38% cost was estimated due to inpatient hospital stays which can be reduced to quite good extent as the tumor ablation demands short duration of hospital stay.Rising prevalence of target diseases such as lung and liver cancer due to various reasons such as unhealthy living styles and hereditary factor, unmet needs of patients demanding drug developments, increased focus of pharmaceutical companies on development of easier methods of testing and monitoring, entry of various players, private investment and governmental funding, and favorable regulatory scenario, increasing demand for less to no pain treatments are some of the key factors driving the market growth in the industry.
New technological innovation of surgical technology taking place such as development in existing radio frequency ablation system now with multi electrode radio frequency system which produces radiofrequency using multi channels.
Augmented demand for patient-centric models has been shaping the ablation devices market for many years.
Moreover, aggressive shift towards minimal invasion, reduced hospitalization rate, greater clinical efficacy, and lower cost is supporting the market growth.
Therefore, FMI projects the net revenue pool to exceed US$ 8 Bn by 2029 end.“Highly sought-after attributes such as proven procedural efficacy, enhanced safety profiles, and greater awareness are fueling the demand for ablation devices in asymptomatic procedure-related events.
Hence, the global ablation devices market will witness stellar growth at approximately 11% CAGR over the forecast period (2019-2029),” says the FMI analyst.Request report sample with 300 pages to gain in-depth insights https://www.futuremarketinsights.com/reports/sample/rep-gb-11254Key Takeaways of Ablation Devices Market StudyAdvanced ablation catheters will continue to stay atop, accounting for 68% revenue in terms of product type.Radiofrequency technology remains highly preferred by manufacturers across the globe.In terms of function, conventional ablation devices will capture leading value proportion over the forecast period.Clinics and hospitals are prominent end users on account of trained medical staff and greater availability of ablation devices.Europe and North America collectively hold 70% share in the overall market stack.Ablation Devices Market – Key Growth FactorsRising adoption of automated robotic ablation devices is stimulating the market growth.Rapid investments by governments in developed countries towards healthcare infrastructure are complementing the growth of ablation devices market.Advancements in state-of-the-art medical equipment will support the market growth over the projection period.Lesser recovery time and lesser potential risks of radiofrequency technology are boosting its wider adoption.Popularity of cryoablation catheters in treating arrhythmias will support the growth of this segment through 2029.Rising life expectancy combined with growing geriatric population are significant revenue contributors of global ablation devices market.Ablation Devices Market – Key RestraintsPotential damage caused by the use ablation devices at the cellular level is limiting the growth of market.
The medical fraternity is giving preference to treat COVID-19 patients while other elective procedures are being postponed worldwide.
Addressing the economic concerns remains the top priority of niche players in the global ablation devices market.Explore the full ablation devices market report with 238 illustrative figures, 78 data tables and table of contents.